trial

Minocycline Augmentation to Clozapine

NCTId NCT02124811
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Completed
Enrollment 10 (actual)
Sponsored by Emory University
Primary completion 2016-11
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Completed
Enrollment
10 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
Triple
Start
2015-02
Primary completion
2016-11
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Minocycline

Sponsors

Emory UniversityLead Sponsor

Investigators

1
Robert O Cotes, MDPrincipal Investigator

Sites

1 total
Atlanta, United States

Facts & assertions

4 sourced
Enrollment
10
Phase
PHASE4
Primary Completion Date
2016-11
Status
COMPLETED
relationships
The graph out of here
drug
Minocycline
drug
lead_sponsor
Emory University
company
indication
Schizoaffective Disorder
indication
Psychotic Disorders
indication
Schizophrenia
indication
investigator
Robert O Cotes, MD
person